The role of COVID‐19 survivor status and gender towards neutralizing antibody titers 1, 2, 3 months after Sinovac vaccine administration on clinical‐year medical students in Indonesia

Background: Sinovac was the first vaccine used in Indonesia against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). However, data regarding the effects of certain variables such as clinical demographics on antibody levels in individuals vaccinated with Sinovac are scarce. This study ai...

Descripción completa

Detalles Bibliográficos
Autores principales: Heriyanto, Rivaldo Steven, Kurniawan, Andree, Wijovi, Felix, Halim, Devina Adella, Jodhinata, Claudia, Marcella, Elizabeth, Susanto, Billy, Wibowo, Johan, Indrawan, Michele, Heryadi, Nadia Khoirunnisa, Imanuelly, Michelle, Anurantha, Jonathan Juniard, Hariyanto, Timotius Ivan, Marcellin, Chintya, Sinaga, Terry Devita, Rizki, Saraswati Anindita, Sieto, Novia, Siregar, Jeremia Immanuel, Lugito, Nata Pratama Hardjo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8507582/
https://www.ncbi.nlm.nih.gov/pubmed/34653654
http://dx.doi.org/10.1016/j.ijid.2021.10.009

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8507582/
https://www.ncbi.nlm.nih.gov/pubmed/34653654
http://dx.doi.org/10.1016/j.ijid.2021.10.009

Ejemplares similares